Black-box warnings could be removed from varenicline.


An independent panel of experts has, by a narrow vote, advised the US Food and Drug Administration (FDA) to remove its black-box warning about severe neuropsychiatric sideeffects from the anti-smoking drug varenicline. The recommendation comes amid worries that the potentially unfounded health warnings might dissuade individuals from taking an otherwise eff… (More)
DOI: 10.1016/S2213-2600(16)30310-1